CAJ | 학술논문

目的：探索“一站式”复合冠状动脉（冠脉）血运重建术治疗SYNTAX高危多支血管病变患者的中期疗效。 　　方法：2007-06至2010-12阜外心血管病医院收治141例冠心病患者，其中男性患者125例。所有患者均为包括左前降支病变在内的多支血管病变，均完成“一站式”复合冠脉血运重建术。依据患者造影资料计算SYNTAX评分，其中有52例患者评分≥30分纳入本研究。研究终点为无主要心脑血管不良事件生存率。 　　结果：本组患者均顺利施行“一站式”复合冠脉血运重建治疗，全部行左乳内动脉至左前降支血管移植，置入药物洗脱支架89枚。全组无手术相关及院内死亡。所有患者均得到随访，平均随访3年，其中3例患者出现支架内狭窄，再次接受经皮冠状动脉介入治疗；2例患者出现脑血管事件。全组无心肌梗死及死亡发生。 　　结论“：一站式”复合冠脉血运重建术治疗SYNTAX高危多支血管病变安全、有效。
목적：탐색“일참식”복합관상동맥（관맥）혈운중건술치료SYNTAX고위다지혈관병변환자적중기료효。 　　방법：2007-06지2010-12부외심혈관병의원수치141례관심병환자，기중남성환자125례。소유환자균위포괄좌전강지병변재내적다지혈관병변，균완성“일참식”복합관맥혈운중건술。의거환자조영자료계산SYNTAX평분，기중유52례환자평분≥30분납입본연구。연구종점위무주요심뇌혈관불량사건생존솔。 　　결과：본조환자균순리시행“일참식”복합관맥혈운중건치료，전부행좌유내동맥지좌전강지혈관이식，치입약물세탈지가89매。전조무수술상관급원내사망。소유환자균득도수방，평균수방3년，기중3례환자출현지가내협착，재차접수경피관상동맥개입치료；2례환자출현뇌혈관사건。전조무심기경사급사망발생。 　　결론“：일참식”복합관맥혈운중건술치료SYNTAX고위다지혈관병변안전、유효。
Objective: To evaluate the midterm outcomes of “one-stop” hybrid coronary revascularization for treating the patients with high SYNTAX score multi-vessel disease. Methods: A total of 141 consecutive coronary artery disease patients with multi-vessel lesion including left anterior descending (LAD) artery stenosis were treated in our hospital from 2007-06 to 2010-12. All patients received “one-stop” hybrid coronary revascularization including 125 male genders. The SYNTAX score was calculated based on angiographic data, and 52 patients with SYNTAX score≥30 were enrolled for investigating the no MACCE (major adverse cardio cerebral vascular events) surviving condition. Results: All patients had successful “one-stop” hybrid coronary revascularization by vascular transplantation from left internal mammary artery (LIMA) to LAD, and 89 drug eluting stents were implanted. There were no surgery related death and no in-hospital death. All patients were followed-up for the average of 3 years, during that period, 3 patients had in-stent stenosis who received re-percutaneous coronary intervention (PCI) and 2 patients suffered from cerebral vascular events, the entire group had no myocardial infarction (MI) and no death. Conclusion: “One-stop” hybrid coronary revascularization is feasible and safe for treating the patients with high SYNTAX score multi-vessel disease.